Management of Psychiatric Disorders in Patients With HIV

  • Author: Glenn J. Treisman, MD, PhD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 11/5/21 (What's New)

Summary

  • Cytochrome P450 enzymes are important in the metabolism of NNRTIs and PIs (including ritonavir) and for many psychotropic drugs
  • Combinations of medications may produce drug-drug interactions
  • Potential interactions between psychotropic medicines and PIs or NNRTIs should be investigated before prescribing together

Action required

Keywords: Drug-Drug Interactions, Psychiatric Disorders, Special Populations

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.